CR

Salesforce IncNYSE CRM Stock Report

Last reporting period 31 Jul, 2024

Updated 17 Sep, 2024

Last price

Market cap $B

245.61

Mega

Exchange

XNYS - New York Stock Exchange, Inc

CRM Stock Analysis

CR

Neutral

Based on Eyestock quantitative analysis, CRM`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

86/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

216.2 %

Greatly undervalued

Market cap $B

245.61

Dividend yield

0.31 %

Shares outstanding

1 000 B

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. The company is headquartered in San Francisco, California and currently employs 79,390 full-time employees. The company went IPO on 2004-06-23. Its Customer 360 platform delivers a source, which connects customer data across systems, applications and devices to help companies sell, service, market and conduct commerce from anywhere. The company focuses on cloud, mobile, social, analytics and artificial intelligence, which connect to its customers and enable companies to transform their businesses. The company also enables third parties to use its platform and developer tools to create additional functionality and applications that run on its platform. Its customers use its sales offering to store data, monitor leads and progress, forecast opportunities, gain insights through analytics and relationship intelligence and deliver quotes, contracts and invoices. Its service offering helps to connect its service agents with customers across any touchpoint. The company helps customers to resolve routine issues with predictions and recommendations.

View Section: Eyestock Rating